Metastatic Cancer Drug Market Key Companies Profile, Supply, Demand and SWOT Analysis - PowerPoint PPT Presentation

About This Presentation
Title:

Metastatic Cancer Drug Market Key Companies Profile, Supply, Demand and SWOT Analysis

Description:

Metastatic cancer is defined as an advanced stage cancer that spreads to other body parts, and the drugs used for the treatment of advanced-stage cancer are known as metastatic cancer drugs. – PowerPoint PPT presentation

Number of Views:0
Slides: 9
Provided by: karan103
Tags:

less

Transcript and Presenter's Notes

Title: Metastatic Cancer Drug Market Key Companies Profile, Supply, Demand and SWOT Analysis


1
Metastatic Cancer Drug Market Global Analysis
and Forecast to 2028
  • Published Date Apr 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • Metastatic Cancer Drug Market Forecast to 2028 -
    COVID-19 Impact and Global Analysis By Cancer
    Type (Breast Cancer, Lung Cancer, Liver Cancer,
    Hematological Cancer, Brain Cancer, Prostate
    Cancer, Pancreatic Cancer, and Others), Route of
    Administration (Intravenous, Intramuscular, Oral,
    and Others), Drug Class (HER2 Inhibitor, Immune
    Checkpoint Inhibitor, PARP Inhibitor, Kinase
    Inhibitor, and Others), Product (Branded and
    Generic Biosimilar), and End User (Hospital,
    Specialty Clinic, and Others)

3
Metastatic Cancer Drug Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 4.2
  • (2021 to 2028)

4
Metastatic Cancer Drug Market Overview
Email sales_at_theinsightpartners.com
  • The metastatic cancer drug market size is
    projected to reach US 68,349.54 million by 2028
    from US 51,157.97 million in 2021. It is
    expected to grow at a CAGR of 4.2 from 2021 to
    2028.
  • Metastatic cancer is defined as an advanced stage
    cancer that spreads to other body parts, and the
    drugs used for the treatment of advanced-stage
    cancer are known as metastatic cancer drugs.
    These drugs are used via various therapies, such
    as chemotherapy, immunotherapy, and targeted
    therapy.

5
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • Cancer Type (Breast Cancer, Lung Cancer, Liver
    Cancer, Hematological Cancer, Brain Cancer,
    Prostate Cancer, Pancreatic Cancer, and Others)
  • Route of Administration (Intravenous,
    Intramuscular, Oral, and Others)
  • Drug Class (HER2 Inhibitor, Immune Checkpoint
    Inhibitor, PARP Inhibitor, Kinase Inhibitor, and
    Others)
  • Product (Branded and Generic Biosimilar)
  • End User (Hospital, Specialty Clinic, and Others)

6
Company Profiles
Email sales_at_theinsightpartners.com
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. HOFFMANN-LA ROCHE LTD.
  • Novartis AG
  • ASTRAZENECA PLC.
  • Eli Lilly and Company
  • MERCK KGaA
  • Pfizer Inc. (Arena Pharmaceutical GmbH)

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com